180 related articles for article (PubMed ID: 32083975)
1. Cardiac-specific inactivation of
Nam JM; Lim JE; Ha TW; Oh B; Kang JO
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H764-H777. PubMed ID: 32083975
[TBL] [Abstract][Full Text] [Related]
2. Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-β Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice.
Sun B; Rouzbehani OMT; Kramer RJ; Ghosh R; Perelli RM; Atkins S; Fatahian AN; Davis K; Szulik MW; Goodman MA; Hathaway MA; Chi E; Word TA; Tunuguntla H; Denfield SW; Wehrens XHT; Whitehead KJ; Abdelnasser HY; Warren JS; Wu M; Franklin S; Boudina S; Landstrom AP
Circ Heart Fail; 2023 Dec; 16(12):e010351. PubMed ID: 38113297
[TBL] [Abstract][Full Text] [Related]
3.
Kramer RJ; Fatahian AN; Chan A; Mortenson J; Osher J; Sun B; Parker LE; Rosamilia MB; Potter KB; Moore K; Atkins SL; Rosenfeld JA; Birjiniuk A; Jones E; Howard TS; Kim JJ; Scott DA; Lalani S; Rouzbehani OMT; Kaplan S; Hathaway MA; Cohen JL; Asaki SY; Martinez HR; Boudina S; Landstrom AP
Circ Genom Precis Med; 2023 Aug; 16(4):390-400. PubMed ID: 37395136
[TBL] [Abstract][Full Text] [Related]
4. PRDM16 Is a Compact Myocardium-Enriched Transcription Factor Required to Maintain Compact Myocardial Cardiomyocyte Identity in Left Ventricle.
Wu T; Liang Z; Zhang Z; Liu C; Zhang L; Gu Y; Peterson KL; Evans SM; Fu XD; Chen J
Circulation; 2022 Feb; 145(8):586-602. PubMed ID: 34915728
[TBL] [Abstract][Full Text] [Related]
5. Prdm16 mutation determines sex-specific cardiac metabolism and identifies two novel cardiac metabolic regulators.
Kühnisch J; Theisen S; Dartsch J; Fritsche-Guenther R; Kirchner M; Obermayer B; Bauer A; Kahlert AK; Rothe M; Beule D; Heuser A; Mertins P; Kirwan JA; Berndt N; MacRae CA; Hubner N; Klaassen S
Cardiovasc Res; 2024 Feb; 119(18):2902-2916. PubMed ID: 37842925
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
7. A cardiac-null mutation of Prdm16 causes hypotension in mice with cardiac hypertrophy via increased nitric oxide synthase 1.
Kang JO; Ha TW; Jung HU; Lim JE; Oh B
PLoS One; 2022; 17(7):e0267938. PubMed ID: 35862303
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
[TBL] [Abstract][Full Text] [Related]
9. PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy.
Hu T; Wu Q; Yao Q; Yu J; Jiang K; Wan Y; Tang Q
Metabolism; 2023 Sep; 146():155658. PubMed ID: 37433344
[TBL] [Abstract][Full Text] [Related]
10. TGF-β
Salvarani N; Maguy A; De Simone SA; Miragoli M; Jousset F; Rohr S
Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004567. PubMed ID: 28500173
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease.
Derangeon M; Montnach J; Cerpa CO; Jagu B; Patin J; Toumaniantz G; Girardeau A; Huang CLH; Colledge WH; Grace AA; Baró I; Charpentier F
Cardiovasc Res; 2017 Apr; 113(5):464-474. PubMed ID: 28339646
[TBL] [Abstract][Full Text] [Related]
12. Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy.
Arndt AK; Schafer S; Drenckhahn JD; Sabeh MK; Plovie ER; Caliebe A; Klopocki E; Musso G; Werdich AA; Kalwa H; Heinig M; Padera RF; Wassilew K; Bluhm J; Harnack C; Martitz J; Barton PJ; Greutmann M; Berger F; Hubner N; Siebert R; Kramer HH; Cook SA; MacRae CA; Klaassen S
Am J Hum Genet; 2013 Jul; 93(1):67-77. PubMed ID: 23768516
[TBL] [Abstract][Full Text] [Related]
13. Improved Biomarker and Imaging Analysis for Characterizing Progressive Cardiac Fibrosis in a Mouse Model of Chronic Chagasic Cardiomyopathy.
Hoffman KA; Reynolds C; Bottazzi ME; Hotez P; Jones K
J Am Heart Assoc; 2019 Nov; 8(22):e013365. PubMed ID: 31718442
[TBL] [Abstract][Full Text] [Related]
14. Loss of cardiomyocyte integrin-linked kinase produces an arrhythmogenic cardiomyopathy in mice.
Quang KL; Maguy A; Qi XY; Naud P; Xiong F; Tadevosyan A; Shi YF; Chartier D; Tardif JC; Dobrev D; Nattel S
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):921-32. PubMed ID: 26071395
[TBL] [Abstract][Full Text] [Related]
15. Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure.
Cibi DM; Bi-Lin KW; Shekeran SG; Sandireddy R; Tee N; Singh A; Wu Y; Srinivasan DK; Kovalik JP; Ghosh S; Seale P; Singh MK
Cell Rep; 2020 Oct; 33(3):108288. PubMed ID: 33086060
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice.
Chiao YA; Ramirez TA; Zamilpa R; Okoronkwo SM; Dai Q; Zhang J; Jin YF; Lindsey ML
Cardiovasc Res; 2012 Dec; 96(3):444-55. PubMed ID: 22918978
[TBL] [Abstract][Full Text] [Related]
17. Changes in Cx43 and NaV1.5 expression precede the occurrence of substantial fibrosis in calcineurin-induced murine cardiac hypertrophy.
Fontes MS; Raaijmakers AJ; van Doorn T; Kok B; Nieuwenhuis S; van der Nagel R; Vos MA; de Boer TP; van Rijen HV; Bierhuizen MF
PLoS One; 2014; 9(1):e87226. PubMed ID: 24498049
[TBL] [Abstract][Full Text] [Related]
18. Experimental Modeling Supports a Role for MyBP-HL as a Novel Myofilament Component in Arrhythmia and Dilated Cardiomyopathy.
Barefield DY; Puckelwartz MJ; Kim EY; Wilsbacher LD; Vo AH; Waters EA; Earley JU; Hadhazy M; Dellefave-Castillo L; Pesce LL; McNally EM
Circulation; 2017 Oct; 136(16):1477-1491. PubMed ID: 28778945
[TBL] [Abstract][Full Text] [Related]
19. Remodeling of repolarization and arrhythmia susceptibility in a myosin-binding protein C knockout mouse model.
Toib A; Zhang C; Borghetti G; Zhang X; Wallner M; Yang Y; Troupes CD; Kubo H; Sharp TE; Feldsott E; Berretta RM; Zalavadia N; Trappanese DM; Harper S; Gross P; Chen X; Mohsin S; Houser SR
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H620-H630. PubMed ID: 28646025
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte-specific Bmal1 deletion in mice triggers diastolic dysfunction, extracellular matrix response, and impaired resolution of inflammation.
Ingle KA; Kain V; Goel M; Prabhu SD; Young ME; Halade GV
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1827-36. PubMed ID: 26432841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
